论文部分内容阅读
据JClinonco（lo；17：4if）载：美国Claxnon大夫等报告了m期癌症和白血病试验和美国东部组采用碳铂作为放疗增敏剂治疗不能切除的非小细胞肺癌（NSCIn），是否能延长患者生存时间的研究结果。纳入研究283例，均先接受5周长春花碱和碳铂化疗，继以＆XX）CCy小W。治疗组在接受放
According to JClinonco (lo;17:4if): Dr. Claxnon et al. reported that the m-phase cancer and leukemia trials and the eastern US group used carboplatin as a radiation sensitizer to treat unresectable non-small cell lung cancer (NSCIn). Patient survival study results. In the 283 cases included in the study, all received vinblastine and carboplatin chemotherapy for 5 weeks, followed by &XX) CCy. The treatment group received